Chronic Active Antibody-mediated Rejection: Opportunity to Determine the Role of Interleukin-6 Blockade. Berger M, Baliker M, Van Gelder T, Bohmig GA, et al. Transplantation 2024;108:1109-1114.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Berger M, Baliker M, Van Gelder T, Bohmig GA, et al. Chronic Active Antibody-mediated Rejection: Opportunity to Determine the Role of Interleukin-6 Blockade. Transplantation 2024;108:1109-1114.
PMID: 37941113